SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose‐lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: a systematic review.
Journal article published in 2020 by
Carlos Escobar,
Vivencio Barrios,
Juan Cosín,
José María Gámez Martínez,
José María Gámez Martínez,
Ana Isabel Huelmos Rodrigo,
Ana Isabel Huelmos Rodrigo,
Carolina Ortíz Cortés,
Mª José Martínez Zapata,
Carolina Ortíz Cortés,
Javier Torres Llergo,
Javier Torres Llergo,
Carolina Requeijo 
,
Ivan Solà,
Mª José Martínez Zapata
,
Ivan Solà,
Mª José Martínez Zapata
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 